National Amyloidosis Centre (NAC) Risk Score Calculator
- National Amyloidosis Centre (NAC) Risk Score: Explanation and Clinical Context
The NAC staging system stratifies patients with transthyretin cardiac amyloidosis (ATTR-CA) into prognostic categories based on NT-proBNP and eGFR levels. Stage 1 indicates a lower risk of mortality, while Stage 3 denotes a higher risk. This system aids clinicians in assessing disease severity and guiding treatment decisions.
Reference:
Nitsche C, et al. Expansion of the National Amyloidosis Centre staging system to detect early mortality risk in transthyretin cardiac amyloidosis. Eur J Heart Fail. 2024;26(7):1234-1242. doi:10.1002/ejhf.2997
QUALITY & SAFETY
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.
Please describe the issue clearly. For calculation concerns, include the input values and expected result where possible.